SS-31 vs MOTS-c: Mitochondrial Peptide Research Comparison
SS-31 works on the inner mitochondrial membrane; MOTS-c is a signal the mitochondrial genome sends to the rest of the cell. A head-to-head research comparison, and why the two are often studied together.
"SS-31 vs MOTS-c" and "SS-31 and MOTS-c" are two sides of the same search: researchers want to know how the two mitochondrial peptides differ, and why they keep turning up together. SS-31 and MOTS-c both belong to mitochondrial research, but they come from different places, act at different levels of the organelle, and are measured with different readouts. This comparison lays out those differences as the published literature describes them, strictly for in-vitro and animal-model research context.
Origins: a designed peptide and an encoded one
The clearest way to separate the two is by where each comes from. SS-31 is synthetic. It belongs to the Szeto-Schiller peptide series, a family designed to reach mitochondria, and it is also known by its development names elamipretide and MTP-131. Its four residues alternate between basic (positively charged) and aromatic amino acids: D-Arg-Dmt-Lys-Phe-NH2, where Dmt is 2',6'-dimethyltyrosine. That aromatic-cationic motif is what carries it to the inner mitochondrial membrane.
MOTS-c is natural in origin. It is a 16-amino-acid peptide encoded by a short open reading frame within the 12S rRNA region of mitochondrial DNA, which makes it one of the mitochondrial-derived peptides (MDPs), alongside humanin. The research-grade MOTS-c reference standard is a synthetic copy of that encoded sequence. One peptide was engineered to target the organelle; the other is written in the organelle's own genome.
SS-31 vs MOTS-c: how each is studied
SS-31: structural, at the inner membrane
SS-31 research centers on cardiolipin, a phospholipid found almost exclusively in the inner mitochondrial membrane. SS-31 binds cardiolipin, and published work examines how that interaction stabilizes the cristae and the respiratory supercomplexes of the electron transport chain. Its accumulation at the inner membrane is reported to be independent of membrane potential, so its uptake does not rely on the charge gradient that many mitochondria-directed compounds need. Typical readouts are oxygen consumption, ATP production and reactive oxygen species. The full mechanism is covered in our what is SS-31 overview.
MOTS-c: signaling, from the mitochondrion outward
MOTS-c is studied as a messenger rather than a structural agent. In cell and animal models it is most associated with activation of AMPK, the cell's central energy sensor, and with glucose- and lipid-metabolism pathways at the cellular level. Cell-model work has also reported that MOTS-c can move into the nucleus under metabolic stress and influence gene expression there, which supports the idea that mitochondria signal back to the nucleus (retrograde signaling). The what is MOTS-c overview goes further.
Side-by-side summary
- Origin: SS-31 is synthetic, from the Szeto-Schiller series. MOTS-c is encoded in the 12S rRNA region of mitochondrial DNA.
- Length: SS-31 is a tetrapeptide (four residues). MOTS-c is 16 amino acids.
- Other names: SS-31 is also elamipretide and MTP-131. MOTS-c is classed as a mitochondrial-derived peptide (MDP).
- Site studied: SS-31 acts at the inner mitochondrial membrane via cardiolipin. MOTS-c acts through cytoplasmic and nuclear signaling.
- Mechanism type: SS-31 is structural and membrane-stabilizing. MOTS-c is a signaling peptide (AMPK, metabolic homeostasis).
- Typical readouts: SS-31 uses oxygen consumption, ATP production, reactive oxygen species and cristae morphology. MOTS-c uses AMPK activation, cellular glucose uptake and gene expression.
- Format: both are supplied lyophilized and reconstituted before assay use.
SS-31 and MOTS-c together: why they are studied as a pair
Because they act at different levels of the same organelle, SS-31 and MOTS-c are complementary research tools rather than substitutes. SS-31 asks a structural question: if the inner membrane and its electron transport machinery are stabilized, does the mitochondrion respire more efficiently and generate fewer reactive oxygen species? MOTS-c asks a signaling question: how does a peptide from the mitochondrial genome change energy sensing and metabolism in the rest of the cell?
Including both lets a research design separate those layers. A model of mitochondrial stress might use SS-31 to probe the membrane and respiratory chain and MOTS-c to probe AMPK-linked signaling, then compare which readouts each one moves. Shared methods such as respirometry give the two a common bench language even though their mechanisms differ. That is a research-design observation, not a recommendation for any combined use; any pairing in the lab is a decision for the researcher's study design, not a claim made here.
Where NAD+ fits: SS-31, MOTS-c and NAD+
Searches for "SS-31, MOTS-c and NAD+" add a third layer. NAD+ is the coenzyme that, as NADH, delivers electrons to complex I of the electron transport chain, the machinery SS-31 research focuses on. AMPK, the pathway central to MOTS-c research, has been linked in the literature to NAD+ metabolism and sirtuin activity. Membrane, signal and cofactor: the three map onto distinct parts of mitochondrial biology. Our what is NAD+ overview covers the coenzyme, and the mitochondrial and energy research collection groups all three.
SS-31 or MOTS-c: which fits a research question?
For reference standards the question is not which peptide is "better" but which mechanism is on the bench. If a study targets membrane integrity, cardiolipin, cristae architecture, electron-transport efficiency or oxidative stress at the respiratory chain, SS-31 matches those models. If it targets energy sensing, AMPK signaling, cellular glucose and lipid handling, or mitochondria-to-nucleus communication, MOTS-c is the fit. Studies asking how the two layers interact are the ones that include both. Neither is ranked against the other, and neither is a product for human use.
Handling both as reference standards
SS-31 and MOTS-c arrive lyophilized and are reconstituted with a diluent such as bacteriostatic water before assay use; the how to reconstitute peptides guide covers the bench steps. The SS-31 reconstitution calculator and MOTS-c reconstitution calculator return concentration and aliquot volumes for each vial size. Both ship in multi-vial research kits from our US facility within 48 hours with tracking.
Frequently asked questions
What is the difference between SS-31 and MOTS-c?
SS-31 (elamipretide, MTP-131) is a synthetic tetrapeptide that binds cardiolipin at the inner mitochondrial membrane and is studied for membrane and electron-transport function. MOTS-c is a 16-amino-acid mitochondrial-derived peptide encoded in mitochondrial DNA and studied for AMPK signaling. One is structural; the other is a signal.
Is SS-31 or MOTS-c better?
That framing does not apply to reference standards. They are studied in different research models, membrane stabilization versus metabolic signaling, and are not ranked on any scale for any application. Neither is a product for human use.
Why are SS-31 and MOTS-c studied together?
Because they probe different layers of mitochondrial biology, some research designs include both to separate structural effects at the inner membrane from signaling effects on AMPK and metabolism. Any such pairing is a study-design decision for the researcher, not a usage recommendation.
What does an "SS-31 and MOTS-c stack" mean in research terms?
In a laboratory context it simply describes a study design that includes both reference standards in the same model. Eon Research does not recommend combining them, and nothing here is guidance for human use.
Is SS-31 the same as elamipretide and MTP-131?
Yes. SS-31, elamipretide and MTP-131 are names for the same mitochondria-targeted tetrapeptide.
How does NAD+ relate to SS-31 and MOTS-c?
NAD+ is a coenzyme, not a peptide. As NADH it feeds electrons to the respiratory chain that SS-31 research focuses on, and the AMPK pathway central to MOTS-c research has been linked to NAD+ metabolism, so the three are often grouped in mitochondrial research.